PPARG and esophageal cancer: Though some small molecule agonist of PPARγ has been shown to reduce the phosphorylation of Akt at Ser473 and exert therapeutic effects in esophageal cancer, the relation between PPARγ protein expression and prognosis in human ESCC still remains unclear [48].